Inverse relation between levels of anti-oxidized-LDL antibodies and eicosapentanoic acid (EPA)

British Journal of Nutrition

Volumn 100, Issue 3, 2008, Pages 585-589

  Garrido Sánchez, Lourdes ^a,b   Garcia Fuentes E ^a,c   Rojo Martinez G ^c,d   Cardona, F ^a,c   Soriguer, F ^d,e   Tinahones, F J ^a,b  

^a Instituto de Salud Carlos III   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

^c Hospital University Carlos Haya de Málaga   (Spain)

^d INSTITUTO DE SALUD CARLOS III   (Spain)

^e HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

Author keywords

Antibodies; Atherosclerosis; Fatty acids; LDL; Oxidized LDL

Indexed keywords

CHOLESTEROL; FATTY ACID DERIVATIVE; GLUCOSE; ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID; OXIDIZED LOW DENSITY LIPOPROTEIN ANTIBODY; PHOSPHOLIPID DERIVATIVE;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FATTY ACID BLOOD LEVEL; FEMALE; GAS CHROMATOGRAPHY; HUMAN; LIPID COMPOSITION; MULTIPLE REGRESSION; PHOSPHOLIPID BLOOD LEVEL; POPULATION RESEARCH; RANDOM SAMPLE; SPAIN; WAIST HIP RATIO;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AUTOANTIBODIES; FATTY ACIDS; FATTY ACIDS, UNSATURATED; FEMALE; HUMANS; LIPOPROTEINS, LDL; MIDDLE AGED; PHOSPHOLIPIDS; REGRESSION ANALYSIS; YOUNG ADULT;

EID: 49649128880     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114508921723     Document Type: Article

References (47)

1. Chobanian AV (1991) Single risk factor intervention may be inadequate to inhibit atherosclerosis progression when hypertension and hypercholesterolemia coexist. Hypertension 18, 130-131.
2. Drake TA, Hannani K, Fei HH, Lavi S & Berliner JA (1991) Minimally oxidized low-density lipoprotein induces tissue factor expression in cultured human endothelial cells. Am J Pathol 138, 601-607.
3. Steinberg D (1997) Oxidative modification of LDL and atherogenesis. Circulation 95, 1062-1071.
4. Esterbauer H, Gebicki J, Puhl H & Jurgens G (1992) The role of lipid peroxidation and antioxidants in oxidative modifications of LDL. Free Radic Biol Med 13, 341-390.
5. Sparrow CP, Parthasarathy S & Steinberg D (1989) A macrophage receptor that recognizes oxidized low density lipoprotein but not acetylated low density lipoprotein. J Biol Chem 264, 2599-2604.
6. Berliner JA, Territo MC, Sevanian A, et al. (1990) Minimally modified low density 'lipoprotein stimulates monocyte endothelial interactions. J Clin Invest 85, 1260-1266.
7. Rajavahira TB, Andalibi A, Territo MC, Berliner JA, Navab M, Fogelman AM & Lusis AJ (1990) Induction of endothelial cell expression of granulocyte and macrophage colony stimulating factors by modified low density lipoproteins. Nature 344, 254-257.
8. Palinski W, Rosenfeld ME, Yla-Herttuala S, et al. (1989) Low density lipoprotein undergoes oxidative modification in vivo. Proc Natl Acad Sci U S A 86, 1372-1376.
9. Craig W (1995) Autoantibodies against oxidized low density lipoportein: a review of clinical findings and assay methodology. J Clin Lab Anal 9, 70-74.
10. Karabinos IK, Koulouris S, Melpidou A, et al. (2003) Increased serum titers of autoantibodies against oxidized LDL cholesterol in young healthy adults: An evidence of a protective effect of these antibodies? Hellenic J Cardiol 44, 374-384.
11. Lehtimaki T, Lehtinen S, Solakivi T, et al. (1999) Autoantibodies against oxidized low density lipoprotein in patients with angiographically verified coronary artery disease. Arterioscler Thromb Vasc Biol 19, 23-27.
12. Inoue T, Uchida T, Kamishirado H, et al. (2001) Clinical significance of antibody against oxidized low density lipoprotein in patients with atherosclerotic coronary artery disease. J Am Coll Cardiol 37, 775-779.
13. Shoji T, Nishizawa Y, Fukumoto M, et al. (2000) Inverse relationship between circulating oxidized low density lipoprotein (oxLDL) and anti-oxLDL antibody levels in healthy subjects. Atherosclerosis 148, 171-177.
14. Yla-Herttuala S, Palinski W, Rosenfeld ME, et al. (1989) Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J Clin Invest 84, 1086-1095.
15. Abbey M, Belling GB, Noakes M, Hirata F & Nestel PJ (1993) Oxidation of low-density lipoproteins: Intraindividual variability and the effect of dietary linoleate supplementation. Am J Clin Nutr 57, 391-398.
16. Reaven PD, Parthasarathy S, Grasse BJ, Miller E, Steinberg D & Witztum J (1993) Effects of oleate-rich and linoleate-rich diets on the susceptibility of low density lipoprotein to oxidative modification in mildly hypercholesterolemic subjects. J Clin Invest 91, 668-676.
17. Gradek WQ, Harris MT, Yahia N, Davis WW, Le NA & Brown WV (2004) Polyunsaturated fatty acids acutely suppress antibodies to malondialdehyde-modified lipoproteins in patients with vascular disease. Am J Cardiol 93, 881-885.
18. Le NA, Li X, Kyung S & Brown WV (2000) Evidence for the in vivo generation of oxidatively modified epitopes in patients with atherosclerotic endothelium. Metabolism 49, 1271-1277.
19. Folch J, Lees M & Sloane Stanley GM (1957) A simple method for the isolation and purification of total lipides from animal tissue. J Biol Chem 226, 497-509.
20. Lepage G & Roy CC (1986) Direct tranesterification of all classes of lipids in a one-step reaction. J Lipid Res 27, 114-120.
21. Tinahones FJ, Gomez-Zumaquero JM, Rojo-Martinez G, et al. (2002) Increased levels of anti-oxidized low-density lipoprotein antibodies are associated with reduced levels of cholesterol in the general population. Metabolism 51, 429-431.
22. Tinahones FJ, Gomez-Zumaquero JM, Garrido-Sanchez L, et al. (2005) Influence of age and sex on levels of anti-oxidized LDL antibodies and anti-LDL immune complexes in the general population. J Lipid Res 46, 452-457.
23. Balada E, Ordi-Ros J, Matas L, Mauri M, Bujan S & Vilardell-Tarres M (2002) Atherosclerosis and anti-oxidized low density lipoprotein antibodies in an elderly population. Med Clin (Barc) 119, 161-165.
24. Festa A, Kopp HP, Schernthaner G & Menzel EJ (1998) Auto-antibodies to oxidised low density lipoproteins in IDDM are inversely related to metabolic control and microvascular complications. Diabetologia 41, 350-356.
25. Karvonen J, Paivansalo M, Kesaniemi YA & Horkko S (2003) Immunoglobulin M type of autoantibodies to oxidized low-density lipoprotein has an inverse relation to carotid artery atherosclerosis. Circulation 108, 2107-2112.
26. Horkko S, Bird DA, Miller E, et al. (1999) Monoclonal auto-antibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins. J Clin Invest 103, 117-128.
27. Freigang S, Horkko S, Miller E, Witztum JL & Palinski W (1998) Immunization of LDL receptor-deficient mice with homologous malondialdehyde-modified and native LDL reduces progression of atherosclerosis by mechanisms other than induction of high titers of antibodies to oxidative neoepitopes. Arterioscler Thromb Vasc Biol 18, 1972-1982.
28. GISSI-Prevenzione Investigators (1999) Dietary supplementation with n 3 polyunsaturated fatty acids and vitamin E after myocardial infarction: Results of the GISSI-Prevenzione trial. Lancet 354 447-455.
29. Burr ML, Fehily AM, Gilbert JF, et al. (1989) Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet ii, 757-761.
30. Schmidt EB, Kristensen SD, De Caterina R & Illingworth DR (1993) The effects of n-3 fatty acids on plasma lipids and lipoproteins and the other cardiovascular risk factors in patients with hyperlipidemia. Atherosclerosis 103, 107-121.
31. Levine PH, Fisher N, Schneider PB, et al. (1989) Dietary supplementation with omega-3 fatty acids prolongs platelet survival in hyperlipidemic patients with atherosclerosis. Arch Intern Med 149, 1113-1116.
32. Singer P, Wirth M, Berger I, et al. (1985) Influence of serum lipids, lipoproteins and blood pressure of mackerel and herring diet in patients with type IV and V hyperlipoproteinemia. Atherosclerosis 56, 111-118.
33. Green P, Fuchs J & Schoenfeld N (1990) Effects of fish oil ingestion on cardiovascular risk factors in hyperlipidemic subjects in Israel: A randomized, double-blind crossover study. Am J Clin Nutr 52, 1118-1124.
34. Kinsella JE, Lokesh B & Stone RA (1990) Dietary n-3 polyunsaturated fatty acids and amelioration of cardiovascular disease: possible mechanisms. Am J Clin Nutr 52, 1-28.
35. Witztum JL & Steinberg D (1991) Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest 88, 1785-1792.
36. Tsai PJ & Lu SC (1997) Fish oil lowers plasma lipid concentrations and increases the susceptibility of low density lipoprotein to oxidative modification in healthy men. J Form Med Assoc 96, 718-726.
37. Suzukawa M, Ishikawa T, Yoshida H & Nakamura H (1995) Effect of in vivo supplementation with low-dose vitamin E on susceptibility of low-density lipoprotein and high-density lipoprotein to oxidative modification. J Am Coll Nutr 14, 46-52.
38. Higdon JV, Du SH, Lee YS, Wu T & Wander RC (2001) Supplementation of postmenopausal women with fish oil does not increase overall oxidation of LDL ex vivo compared to dietary oils rich in oleate and linoleate. J Lipid Res 42, 407-418.
39. Mesa MD, Buckley R, Marieinibane A & Yaqoob R (2004) Effects of oils rich in eicosapentaenoic and docosahexaenoic acids on theoxidizability and thrombogenicity of low-density lipoprotein. Atherosclerosis 175, 333-343.
40. Nomura S, Kanazawa S & Fukuhara S (2003) Effects of eicosapentaenoic acid on platelet activation markers and cell adhesion molecules in hyperlipidemic patients with type 2 diabetes mellitus. J Diabetes Complications 17, 153-159.
41. Johansen O, Seljeflot I, Hostmark AT & Arnesen H (1999) The effect of supplementation with omega-3 fatty acids on soluble markers of endothelial function in patients with coronary heart disease. Arterioscler Thromb Vasc Biol 19, 1681-1686.
42. Thies F, Miles EA, Nebe-von-Caron G, et al. (2001) Influence of dietary supplementation with long-chain n-3 or n-6 polyunsaturated fatty acids on blood inflammatory cell populations and functions and on plasma soluble adhesion molecules in healthy adults. Lipids 36, 1183-1193.
43. Aguilera CM, Ramirez-Tortosa MC, Mesa MD, Ramirez-Tortosa CL & Gil A (2002) Sunflower, virgin-olive and fish oils differentially affect the progression of aortic lesions in rabbits with experimental atherosclerosis. Atherosclerosis 162, 335-344.
44. Hu FB, Bronner L, Willett WC, et al. (2002) Fish and omega-3 fatty acid intake and risk of coronary heart disease in women. JAMA 287, 1815-1821.
45. Harris WS (1989) Fish oils and plasma lipid and lipoprotein metabolism in humans: A critical review. J Lipid Res 30, 785-807.
46. Alexander JW (1998) Immunonutrition: The role of omega-3 fatty acids. Nutrition 14, 627-633.
47. Simopoulos AP (1991) Omega-3 fatty acids in health and disease and in growth and development. Am J Clin Nutr 54, 438-463.